LGC Clinical Diagnostics
LGC Clinical Diagnostics has over 35 years of experience as a leading and trusted global manufacturer of Quality Management Tools (QMT) and reagent components. We partner with In Vitro Diagnostics (IVD) and biopharmaceutical developers, clinical research organizations (CROs) and academic institutions in commercialization activities across the entire diagnostic pipeline - from concept and early-stage research, through expedited product development and onwards into routine clinical use. Laboratories and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics, and clinical genomics rely on LGC’s products to achieve accurate and reliable diagnostic results.
Our combined and ever-growing capabilities mean we are better positioned to support the needs of the clinical diagnostics industry, from early feasibility and research to commercial & laboratory development test (LDT) assay development, installation, validation and ongoing performance monitoring support. LGC Clinical Diagnostics Quality Management and reagent component manufacturing facilities are FDA-registered, and ISO 13485 and ISO 9001-certified.
Our brands include three IVD manufacturers of QMTs and one manufacturer of viral and bacterial antigens and antibodies:
Maine Standards Company Calibration verification materials, validation & qualification panels, calibrators, and OEM PT/EQA samples
SeraCare Quality Controls, Reference Materials, Biological Materials, reagent components
Technopath Clinical Diagnostics Independent Quality Controls & QC Software Solutions
The Native Antigen Company Viral and bacterial antigens/antibodies
Together, our brands serve over 7,500 customers in over 120 countries, providing products for more than 20 clinical application areas, including infectious diseases, NIPT, diabetes, cardiac disease and oncology.
About LGC Group
LGC Group is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. The company's high quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within their customers’ products and workflows and are valued for their performance, quality and range.
LGC tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to: bring new diagnostics and therapies to market; progress research and development; optimize food production; and continuously monitor and enhance the quality of food, the environment and consumer products.
LGC’s 175+ years of scientific heritage, combined with a track record of innovation and value-enhancing acquisitions, has enabled the company to build its product portfolio and expertise, and develop deep relationships with customers, industry partners and the global scientific community.
Contact LGC Clinical Diagnostics
Whether releasing patient results with confidence or advancing cutting-edge research, you need a partner that is responsive, reliable and agile. Please get in touch and see how we can collaborate to change the future of clinical diagnostics.Get in Touch